Elizabeth Ness

1.0k total citations
18 papers, 784 citations indexed

About

Elizabeth Ness is a scholar working on Molecular Biology, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elizabeth Ness has authored 18 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in General Health Professions and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elizabeth Ness's work include Ethics in Clinical Research (3 papers), Peptidase Inhibition and Analysis (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Elizabeth Ness is often cited by papers focused on Ethics in Clinical Research (3 papers), Peptidase Inhibition and Analysis (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Elizabeth Ness collaborates with scholars based in United States. Elizabeth Ness's co-authors include Michael Hawkins, Slawomir Wojtowicz‐Praga, John L. Marshall, Mark Sale, Michael D. Johnson, Naiyer A. Rizvi, John B. Marshall, Rita A. Dickson, Thomas A. Chiodo and William Dahut and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Cancer Biology & Therapy.

In The Last Decade

Elizabeth Ness

18 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Ness United States 13 356 341 262 93 89 18 784
D C Talbot United Kingdom 14 343 1.0× 383 1.1× 277 1.1× 26 0.3× 48 0.5× 26 748
Teresita Muñoz-Antonia United States 17 631 1.8× 375 1.1× 165 0.6× 51 0.5× 69 0.8× 49 1.0k
Rita Azevedo Portugal 21 529 1.5× 178 0.5× 106 0.4× 39 0.4× 144 1.6× 38 1.0k
Bart C. Kuenen Netherlands 17 511 1.4× 519 1.5× 176 0.7× 84 0.9× 70 0.8× 31 1.2k
Robert L. DeWitty United States 16 272 0.8× 462 1.4× 370 1.4× 51 0.5× 136 1.5× 36 983
Kenneth Villman Sweden 19 323 0.9× 678 2.0× 318 1.2× 35 0.4× 20 0.2× 33 1.1k
Amanda Croft Australia 17 559 1.6× 207 0.6× 119 0.5× 63 0.7× 54 0.6× 34 888
Jason H. Mendler United States 13 322 0.9× 198 0.6× 150 0.6× 54 0.6× 140 1.6× 53 787
Praveen Vikas United States 13 263 0.7× 551 1.6× 158 0.6× 71 0.8× 110 1.2× 27 988
Taner Babacan Türkiye 15 181 0.5× 409 1.2× 217 0.8× 18 0.2× 73 0.8× 52 788

Countries citing papers authored by Elizabeth Ness

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Ness more than expected).

Fields of papers citing papers by Elizabeth Ness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Ness. The network helps show where Elizabeth Ness may publish in the future.

Co-authorship network of co-authors of Elizabeth Ness

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Ness. A scholar is included among the top collaborators of Elizabeth Ness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Ness. Elizabeth Ness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Faupel‐Badger, Jessica M., Amanda L. Vogel, Christopher P. Austin, et al.. (2022). Teaching principles of translational science to a broad scientific audience using a case study approach: A pilot course from the National Center for Advancing Translational Sciences. Journal of Clinical and Translational Science. 6(1). 5 indexed citations
2.
Ness, Elizabeth. (2020). The Oncology Clinical Research Nurse Study Co-Ordinator: Past, Present, and Future. Asia-Pacific Journal of Oncology Nursing. 7(3). 237–242. 13 indexed citations
3.
Ness, Elizabeth, et al.. (2017). Clinical Trials and the Role of the Oncology Clinical Trials Nurse. Nursing Clinics of North America. 52(1). 133–148. 23 indexed citations
4.
Wehrlen, Leslie, et al.. (2016). Systematic collection of patient reported outcome research data: A checklist for clinical research professionals. Contemporary Clinical Trials. 48. 21–29. 12 indexed citations
5.
O’Mara, Ann M., et al.. (2014). Clinical Research Education: Perspectives of Nurses, Employers, and Educators. Journal of Nursing Education. 53(8). 466–472. 5 indexed citations
6.
Frye, Robin, et al.. (2012). Romidepsin: A New Drug for the Treatment of Cutaneous T-Cell Lymphoma. Clinical journal of oncology nursing. 16(2). 195–204. 45 indexed citations
7.
Resnik, David B. & Elizabeth Ness. (2012). Participants’ responsibilities in clinical research. Journal of Medical Ethics. 38(12). 746–750. 21 indexed citations
8.
Setser, Ann & Elizabeth Ness. (2011). An innovative, web-based reporting system for serious adverse events developed by the cancer therapy evaluation program (CTEP), National Cancer Institute (NCI). 10 indexed citations
9.
Castro, Kathleen M., et al.. (2008). Developing Outcomes for an Oncology Nurse Internship Program. Oncology nursing forum. 35(5). 753–756. 2 indexed citations
10.
Calhoun, Elizabeth A., et al.. (2008). A National Patient Navigator Training Program. Health Promotion Practice. 11(2). 205–215. 93 indexed citations
11.
Rizvi, Naiyer A., Jeffrey S. Humphrey, Elizabeth Ness, et al.. (2004). A Phase I Study of Oral BMS-275291, a Novel Nonhydroxamate Sheddase-Sparing Matrix Metalloproteinase Inhibitor, in Patients with Advanced or Metastatic Cancer. Clinical Cancer Research. 10(6). 1963–1970. 47 indexed citations
12.
Marshall, John L., Dorraya El‐Ashry, Michael D. Johnson, et al.. (2002). Phase I Study of Prolonged Infusion Bryostatin-1 in Patients. Cancer Biology & Therapy. 1(4). 409–416. 24 indexed citations
13.
Rizvi, Naiyer A., John L. Marshall, Elizabeth Ness, et al.. (2002). Initial Clinical Trial of Oral TAC-101, a Novel Retinoic Acid Receptor-Alpha Selective Retinoid, in Patients With Advanced Cancer. Journal of Clinical Oncology. 20(16). 3522–3532. 31 indexed citations
14.
Chen, Helen X, John L. Marshall, Elizabeth Ness, et al.. (2000). A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.. PubMed. 6(4). 1259–66. 52 indexed citations
15.
Rizvi, Naiyer A., John L. Marshall, William Dahut, et al.. (1999). A Phase I study of LGD1069 in adults with advanced cancer.. PubMed. 5(7). 1658–64. 88 indexed citations
16.
Wojtowicz‐Praga, Slawomir, Michael D. Johnson, John B. Marshall, et al.. (1998). Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.. Journal of Clinical Oncology. 16(6). 2150–2156. 196 indexed citations
17.
Rizvi, Naiyer A., J L Marshall, Elizabeth Ness, et al.. (1998). Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.. PubMed. 4(6). 1437–42. 23 indexed citations
18.
Wojtowicz‐Praga, Slawomir, Jennifer A. Low, John L. Marshall, et al.. (1996). Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Investigational New Drugs. 14(2). 193–202. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D C Talbot Breakdown of academic impact, for papers by Teresita Muñoz-Antonia Breakdown of academic impact, for papers by Rita Azevedo Breakdown of academic impact, for papers by Bart C. Kuenen Breakdown of academic impact, for papers by Robert L. DeWitty Breakdown of academic impact, for papers by Kenneth Villman Breakdown of academic impact, for papers by Amanda Croft Breakdown of academic impact, for papers by Jason H. Mendler Breakdown of academic impact, for papers by Praveen Vikas Breakdown of academic impact, for papers by Taner Babacan
Rankless by CCL
2026